Gordillo CR, Gómez ML, Hipólito CR, Lamuño EM, Pérez CR

Language: Spanish
References: 33
Page: 201-210
PDF size: 79.89 Kb.

ABSTRACT

Treatment of COPD include several measures as prevention, avoiding and treatment of complications, as well as preservation and enhancement of functional capacity. It has been demonstrated that the elimination of cigarette smoking is related with prolonged survival of patients with COPD and a significant increment of forced expiratory volume in 1 second (FEV₁). Long-term oxygen therapy has been demonstrated to be useful to improve cor pulmonale and activities of daily living; bronchodilators (β₂-adrenergic agonists, anticholinergic and teophylline derivatives) improve dyspnea and exercise tolerance; exogenous α₁ antitripsyn is reserved to treat young patients; the use of glucorticoids decrease the severity of COPD and the need for hospitalization; lung transplantation should be considered for end-stage patients; the benefit of lung volume reduction surgery is limited for as long as three years; assisted mechanical ventilation and noninvasive positive pressure ventilation maybe necessary in the management of an exacerbation of COPD.

REFERENCES

1. Tierney LM, McPhee SJ, Papadakis MA. Enfermedad pulmonar obstructiva crónica. Diagnóstico clínico y tratamiento. 2001:278-279.

2. Mcphee SJ, Ganong WF, Lingappa VR, Lange JD. Fisiopatología de enfermedades pulmonares seleccionadas. Fisiopatología Médica 1999:182-183.

3. Thurlbeck WM. Pathophysiology of chronic obstructive pulmonary disease. Clin Chest Med 1990;11:389-403.

4. Haluzka J, Chartrand DA, Grassino AE, Milic-Emili J. Intrinsic PEEP and arterial PCO2 in stable patients with chronic obstructive pulmonary disease. Am Rev Respir Dis 1990;141:1194-7.

5. Younes M. Load responses, dyspnea, and respiratory failure. Chest 1990;97:58S-59.

6. Macklem PT. Respiratory muscles: The vital pump. Chest 1980;75:753-8.

7. Pardy RL, Revington RN, Despas PJ et al. The effects on inspiratory muscle training on exercise performance in chronic airflow limitation. Am Rev Respir Dis 1981;123: 426-33.

8. Fletcher CM, Elmes PC, Fairbain AS et al. The significance of respiratory symptoms and diagnosis of chronic bronchitis in working population. Br Med J 1959;2:257-66.

9. Chonan T, Cherniack NS, Altose MD. Effects of COPD on behavioral control of breathing. In: Cherniack NS. Chronic obstructive pulmonary disease. Philadelphia: WB Saunders, 1991:127-34.

10. Mahler DA. Dyspnea: Diagnosis and management. Clin Chest Med 1987;8:215-30.

11. Mahler DA, Weinber DH, Wells CK et al. The measurement of dyspnea: Contents, interobserver agreement and physiologic correlates of two new clinical indexes. Chest 1984;85:571-8.

12. Lisboa C, Muñoz V, Leiva A et al. Efecto del entrenamiento muscular inspiratorio por tiempo prolongado en pacientes con limitación crónica del flujo aéreo. Rev Chil Enf Respir 1993;9:70-8.

13. Fraser RG, Paré JAP, Paré PD et al. Diseases of the airways. In: Diagnosis of diseases of the Chest. Vol III. 3rd ed. Philadelphia: WB Saunders, 1990:2116.

14. Bates AV et al. Chronic bronchitis. Report on the third and fourth stages of the coordinated study of chronic bronchitis in the department of veterans officers. Parada Med Serv J Cavi 1966; 22:5.

15. Feigin DS et al. Increase pulmonary markings. Invest Radiol 1980;15:425.

16. Nicklaus TM et al. The accuracy of the roentgenologic diagnosis of chronic pulmonary emphysema. Am Rev Respir Dis 1966;93:889.

17. Simon G et al. Relation between abnormalities in the chest radiography and changes in pulmonary function in chronic bronchitis and emphysema. Thorax 1977;28:15.

18. Simon G. Complexities of emphysema. Frontiers of pulmonary radiology. New York: Grune-Strutton, 1969:142-53.

19. Bergin CJ et al. CT in the qualitative assessment of emphysema. J Torac Imag 1986;1:94.

20. Miller RR, Müller NL, Vedal S, Morrison NJ, Staples CA. Limitations of computed tomography in the assessment of emphysema. Am Rev Respir Dis 1989;139:980-3.

21. Haluzka J, Chartrand DA, Grassino AE, Milic-Emili J. Intrinsic PEEP and arterial PCO2 in stable patients with chronic obstructive pulmonary disease. Am Rev Respir Dis 1990;141:1194-7.

22. Tisi GM. Pulmonary physiology in clinical medicine. Baltimore: Williams & Wilkins, 1980.

23. Anthonisen NR, Wright EC, Hodgkin JE. Prognosis in chronic obstructive pulmonary disease. Am Rev Respir Dis 1986;133:14.

24. West WW, Nagai A, Hodgkin JE, Thurlbeck WN. The National Institutes of Health. III. The diagnosis of emphysema. Am Rev Respir Dis 1987;135:123-9.

25. Crapo RO, Forster RE. Carbon monoxide diffusing capacity. Clin Chest Med 1989;10:187.

26. Owens G, Rogers R, Pennock B, Levin D. The diffusing capacity as a predictor of arterial oxygen desaturation during exercise in patients with chronic obstructive pulmonary disease. N Engl J Med 1984;310:1218.

27. DuBois P, Machiels J, Smeets F et al. CO transfer capacity as a determining factor of survival for severe hipoxaemic COPD patients under long term oxygen therapy. Eur Respir J 1990;3:1042.

28. Killian KJ, Leblanc P, Martin DA, Summers E, Jones NL, Moran CEJ. Exercise capacity and ventilatory, circulatory and symptom limitation in patients with chronic airflow limitation. Am Rev Respir Dis 1992;146:935-40.

29. Butland RJA, Pang J, Gross ER, Woodcok AA et al. Two, six and 12 minute walking test in respiratory disease. Br Med J 1982;284:1607.

30. McGiven CR, Gupta SP, McHardy GJR. Twelve-minute walking test for assessing disability in chronic bronchitis. Br Med J 1976;1:822.

31. Cooper KH. A means of assessing maximal oxygen uptake. JAMA 1968;203:135.

32. Mungall IPF, Hainsworth R. Assessment of respiratory function in patients with chronic obstructive airways disease. Thorax 1980;34:254.

33. Wagner PD, Dantzker DR, Dueck R et al. Ventilation-perfusion inequality in chronic obstructive pulmonary disease. J Clin Invest 1977;59:203.